These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 1591301)

  • 1. Purging in autologous and allogeneic bone marrow transplantation.
    Gulati SC; Lemoli RM; Acaba L; Igarashi T; Wasserheit C; Fraig M
    Curr Opin Oncol; 1992 Apr; 4(2):264-71. PubMed ID: 1591301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improving the role of hematopoietic support for high-dose cytotoxic therapy.
    Gulati SC; Acaba L
    Cancer Invest; 1993; 11(3):319-26. PubMed ID: 8097959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Future paradigm for autologous bone marrow transplantation: tumor purging and ex vivo production of normal stem and progenitor cells.
    Rummel SA; Van Zant G
    J Hematother; 1994; 3(3):213-8. PubMed ID: 7827869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Purging of autologous bone marrow for transplantation: the protection and selection of the hematopoietic progenitor cell.
    Shpall EJ; Stemmer SM; Johnston CF; Hami L; Bearman SI; Berenson R; Jones RB
    J Hematother; 1992; 1(1):45-54. PubMed ID: 1365017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous bone marrow transplantation for leukemia.
    Stuart RK
    Semin Oncol; 1993 Oct; 20(5 Suppl 6):40-54. PubMed ID: 8211215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical applications of CD34+ cell-selected peripheral blood stem cells.
    Kawabata Y; Hirokawa M; Komatsuda A; Sawada K
    Ther Apher Dial; 2003 Jun; 7(3):298-304. PubMed ID: 12924604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Technical aspects of autologous bone marrow transplantation].
    Handgretinger R; Klingebiel T; Niethammer D
    Infusionsther Transfusionsmed; 1994 Nov; 21 Suppl 3():39-41. PubMed ID: 7841779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New approaches to treating malignances with stem cell transplantation.
    Margolis J; Borrello I; Flinn IW
    Semin Oncol; 2000 Oct; 27(5):524-30. PubMed ID: 11049020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graft purging in autologous bone marrow transplantation: a promise not quite fulfilled.
    Alvarnas JC; Forman SJ
    Oncology (Williston Park); 2004 Jun; 18(7):867-76; discussion 876-8, 881, 884. PubMed ID: 15255171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow purging for autologous bone marrow transplantation.
    Gribben JG; Nadler LM
    Leuk Lymphoma; 1993; 11 Suppl 2():141-8. PubMed ID: 8124225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mechanisms involved in the impairment of hematopoiesis after autologous bone marrow transplantation.
    Domenech J; Roingeard F; Binet C
    Leuk Lymphoma; 1997 Jan; 24(3-4):239-56. PubMed ID: 9156654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous bone marrow transplantation with negative immunomagnetic purging for aggressive B-cell non-Hodgkin's lymphoma in first complete remission.
    De Rosa L; Lalle M; Pandolfi A; Ruscio C; Amodeo R
    Ann Hematol; 2002 Oct; 81(10):575-81. PubMed ID: 12424539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Autologous bone marrow transplantation for patients with chronic myelogenous leukemia after in vitro purging of the graft with bcr/abl antisense oligodeoxynucleotides].
    Sun J; Wu B; Liu Q; Feng R; Liu X; Meng F; Zhou S
    Zhonghua Xue Ye Xue Za Zhi; 2000 Aug; 21(8):400-2. PubMed ID: 11877009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guanine arabinoside as a bone marrow-purging agent.
    Kurtzberg J
    Ann N Y Acad Sci; 1993 Jun; 685():225-36. PubMed ID: 8363226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and toxicity of 9-beta-D-arabinofuranosylguanine (araG) as an agent to purge malignant T cells from murine bone marrow: application to an in vivo T-leukemia model.
    Gravatt LC; Chaffee S; Hebert ME; Halperin EC; Friedman HS; Kurtzberg J
    Leukemia; 1993 Aug; 7(8):1261-7. PubMed ID: 8350627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primed marrow for autologous and allogeneic transplantation: a review comparing primed marrow to mobilized blood and steady-state marrow.
    Elfenbein GJ; Sackstein R
    Exp Hematol; 2004 Apr; 32(4):327-39. PubMed ID: 15050742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ex-vivo treatment of a bone marrow graft].
    Bieva CJ
    Rev Med Brux; 1992 May; 13(5):177-82. PubMed ID: 1609193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New developments in stem cell detection and stem cell selection in the context of autologous transplantations.
    Douay L; Lopez M; Giarratana MC; Bony V; Bouchet S; Gorin NC
    Nouv Rev Fr Hematol (1978); 1993 Feb; 35(1):87-9. PubMed ID: 8099734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow-resident memory T cells survive pretransplant chemotherapy and contribute to early immune reconstitution of patients with acute myeloid leukemia given mafosfamide-purged autologous bone marrow transplantation.
    Casorati G; Locatelli F; Pagani S; Garavaglia C; Montini E; Lisini D; Turin I; Rossi F; Dellabona P; Maccario R; Montagna D
    Exp Hematol; 2005 Feb; 33(2):212-8. PubMed ID: 15676215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of allogeneic transplant morbidity by combining peripheral blood and bone marrow progenitor cells.
    Nemunaitis J; Albo V; Zeigler ZR; Shadduck RK; Rosenfeld CS
    Leuk Lymphoma; 1993 Jul; 10(4-5):405-6. PubMed ID: 8106066
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.